Compounds > peroxynitrous acid
Page last updated: 2024-09-03

peroxynitrous acid and papaverine

peroxynitrous acid has been researched along with papaverine in 1 studies

Compound Research Comparison

Studies
(peroxynitrous acid)		Trials
(peroxynitrous acid)		Recent Studies (post-2010)
(peroxynitrous acid)		Studies
(papaverine)		Trials
(papaverine)		Recent Studies (post-2010) (papaverine)
3,303211,2306,027305355

Protein Interaction Comparison

ProteinTaxonomyperoxynitrous acid (IC50)papaverine (IC50)
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10ARattus norvegicus (Norway rat)0.076
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)2.3
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)8.8
3',5'-cyclic-AMP phosphodiesterase Sus scrofa (pig)1.7
Bile salt export pumpHomo sapiens (human)10
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)1.6
Cytochrome P450 2C19Homo sapiens (human)0.762
Serine hydroxymethyltransferase, mitochondrialHomo sapiens (human)2.6915
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1AHomo sapiens (human)9
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BHomo sapiens (human)9
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)1.4
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)7.2444
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)1.03
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CHomo sapiens (human)9
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)0.697
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus (Norway rat)0.036
Phosphodiesterase Sus scrofa (pig)0.62
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AHomo sapiens (human)0.07

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blancas-Mejia, LM; Burciu, C; Franco, DA; Guzman-Villanueva, D; Hari, P; Karamanova, N; Lindsay, S; Migrino, RQ; Ramirez-Alvarado, M; Senapati, S; Truran, S; Weissig, V1

Other Studies

1 other study(ies) available for peroxynitrous acid and papaverine

ArticleYear
Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins.
    Journal of the American Heart Association, 2016, 06-13, Volume: 5, Issue:6

    Topics: Adipose Tissue; Arterioles; Cell Survival; Cholesterol; Drug Combinations; Endothelial Cells; Endothelium, Vascular; Gangliosides; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; NAD(P)H Dehydrogenase (Quinone); Nanoparticles; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type III; Papaverine; Peroxynitrous Acid; Phosphatidylcholines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Superoxides; Transfection; Vascular Diseases; Vasodilator Agents

2016